Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 29: | Line 29: | ||
* Scaly | * Scaly | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Fair-skinned individuals: sites frequently exposed to the sun | * Fair-skinned individuals: sites frequently exposed to the sun | ||
Line 89: | Line 90: | ||
* Prominent keratinous core in the center of the nodule | * Prominent keratinous core in the center of the nodule | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Sun-exposed areas | * Sun-exposed areas | ||
Line 110: | Line 112: | ||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | | style="background: #F5F5F5; padding: 5px;" |No more additional findings | ||
| style="background: #F5F5F5; padding: 5px;" |Older patients with light skin tones | | style="background: #F5F5F5; padding: 5px;" |Older patients with light skin tones | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Starts on areas of skin exposed to the sun | * Starts on areas of skin exposed to the sun | ||
Line 127: | Line 130: | ||
| style="background: #F5F5F5; padding: 5px;" |Pink or flesh-colored papule | | style="background: #F5F5F5; padding: 5px;" |Pink or flesh-colored papule | ||
| style="background: #F5F5F5; padding: 5px;" |none | | style="background: #F5F5F5; padding: 5px;" |none | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" |Typically presents on the face | | style="background: #F5F5F5; padding: 5px;" |Typically presents on the face | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 140: | Line 144: | ||
| style="background: #F5F5F5; padding: 5px;" |Erythematous lesion | | style="background: #F5F5F5; padding: 5px;" |Erythematous lesion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 179: | Line 184: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 194: | Line 200: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Head and neck, | * Head and neck, | ||
Line 213: | Line 220: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Cheek | * Cheek | ||
Line 230: | Line 238: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 245: | Line 254: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma in situ''' (Lentigo Maligna) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma in situ''' (Lentigo Maligna) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Macule | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable (from light to dark brown, black, pink, red, or white) | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Smooth | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Around 1 cm | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Sun-damaged skin of the head or neck | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Asymmetric, pigmented follicular openings | |||
* Gray angulated lines | |||
* Gray areas, dots, and globules | |||
* Circle within a circle | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* '''↑''' atypical spindle shaped melanocytes, | |||
* Arranged in single cells or in small nests along the dermoepidermal junction | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Development of darker pigmentation, sharper borders, or nodular areas are signs of progression to lentigo maligna melanoma | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo maligna melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo maligna melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Macule | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Brown/tan | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Freckle-like | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Chronically sun-damaged areas | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Along the dermal-epidermal junction in a lentiginous pattern | |||
* "Star-burst giant cells" at the basal layer of the epidermis | |||
* Poorly cohesive or dyshesive nests along the dermal-epidermal junction forming the "swallow's nest" sign | |||
* Cytoplasm is shrunken and surrounds a pale nucleus with small nucleoli | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Usually in older individuals | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial spreading melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial spreading melanoma''' | ||
Line 270: | Line 301: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 281: | Line 313: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 294: | Line 327: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 338: | Line 372: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 349: | Line 384: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 360: | Line 396: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Variable | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 02:30, 19 February 2019
Diseases | Physical exam | Para-clinical findings | Additional findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Skin Examination | ||||||||||
Diagnosis | ||||||||||
Type | Color | Texture | Size | Distribution | Dermoscopic Findings | Histopathology | Unique features | |||
Cutaneous squamous cell carcinoma | SCC in situ (Bowen's disease) |
|
|
|
|
|
|
|
| |
Invasive squamous cell carcinoma |
|
|
|
|
|
|
|
| ||
Keratoacanthoma |
|
|
|
|
|
|
|
| ||
Merkel cell carcinoma | rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule | No more additional findings | Older patients with light skin tones |
|
|
Milky red areas; linear, irregular vessels; and polymorphous vessels |
|
Blue-red, dome-shaped nodule | ||
Basal cell carcinoma | Nodular basal cell carcinoma | Pearly papule with telangiectasias | Pink or flesh-colored papule | none |
|
Typically presents on the face |
| |||
Superficial basal cell carcinoma | Scaly patch | Erythematous lesion |
|
|
||||||
Prurigo nodules | Firm, dome-shaped and itchy | ranging in size from a few millimeters to several centimeters and often symmetrically distributed | none | Nodules can be flesh-colored, erythematous, or brown/black |
|
|
| |||
Common nevus |
|
|
|
|
||||||
Blue nevus |
|
|
|
|
||||||
Spitz nevus | Nonpigmented Spitz nevus |
|
|
|
|
|
| |||
Reed-like Spitz |
|
|
|
|
| |||||
Melanoma | Melanoma in situ (Lentigo Maligna) |
|
|
|
|
|
|
|
| |
Lentigo maligna melanoma |
|
|
|
|
|
|
| |||
Superficial spreading melanoma |
|
|||||||||
Nodular melanoma |
|
Cells proliferate downwards through the skin (vertical growth) |
| |||||||
Acral lentiginous melanoma |
|
|||||||||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | Red, nonspecific lesion with slightly elevated borders |
| ||||||
Solar lentigo |
|
|
|
|
|
| ||||
Sebaceous hyperplasia |
|
|||||||||
Lichen planus-like keratosis |
|
|||||||||
Seborrheic keratosis |
|
|||||||||
Actinic keratosis | less pigmentation, and tend to be somewhat smaller in size. | Erythema | Hyperkeratosis | painful |
SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia.